Thus, surveying primary AML ACSS1 and ACSS2 expression profiles and the effects of exogenous acetate enhancement on proliferative growth yields the possibility that leukemic cells may uptake acetate from exogenous sources such as the microenvironment and process the metabolite through ACSS1or ACSS2. This evidence concerns the gene ACSS1 and acute myeloid leukemia.